TL Biopharmaceutical AG
-
Franchise India Bureau Sep 29 2017 - 2 min readAurobindo Pharma Limited has announced that it has acquired four cell culture derived biosimilar products from TL Biopharmaceutical AG of Switzerland. The company, however, did not disclose the deal value.As part of the agreement, TL will supply all the developmental data for four molecules and Aurobindo and/or its affiliates will develop, commercialise and market these ...